CTEV
Get informed when a big investor buys or sells
+ FollowOvervalued by 260.5% based on the discounted cash flow analysis.
| Market cap | $501.55 Million |
|---|---|
| Enterprise Value | $5.09 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-17.3 |
| Beta | 0.77 |
| Outstanding Shares | 16,692,340 |
| P/E Ratio | -1.7 |
|---|---|
| PEG | -54.03 |
| Price to Sales | 0.52 |
| Price to Book Ratio | -2.0 |
| Enterprise Value to Revenue | 5.2 |
| Enterprise Value to EBIT | -379.9 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0.91 |
| Debt to Equity | -19.11 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5436▲ 25.54% |
|---|---|
| Total Calls | 67,700▼ 34.53% |
| Total Puts | 36,800▲ 23.49% |
Holdings and activity of institutional investors.
| Ownership % | 86.12%▲ 0.62% |
|---|---|
| Total Invested | $231.48M▼ 61.58% |
| Investors Holding | 99▼ 11.00% |
No data
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-...